Encainide: Difference between revisions

	WikiDoc Resources for Encainide
Articles
Most recent articles on Encainide Most cited articles on Encainide Review articles on Encainide Articles on Encainide in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Encainide Images of Encainide Photos of Encainide Podcasts & MP3s on Encainide Videos on Encainide
Evidence Based Medicine
Cochrane Collaboration on Encainide Bandolier on Encainide TRIP on Encainide
Clinical Trials
Ongoing Trials on Encainide at Clinical Trials.gov Trial results on Encainide Clinical Trials on Encainide at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Encainide NICE Guidance on Encainide NHS PRODIGY Guidance FDA on Encainide CDC on Encainide
Books
Books on Encainide
News
Encainide in the news Be alerted to news on Encainide News trends on Encainide
Commentary
Blogs on Encainide
Definitions
Definitions of Encainide
Patient Resources / Community
Patient resources on Encainide Discussion groups on Encainide Patient Handouts on Encainide Directions to Hospitals Treating Encainide Risk calculators and risk factors for Encainide
Healthcare Provider Resources
Symptoms of Encainide Causes & Risk Factors for Encainide Diagnostic studies for Encainide Treatment of Encainide
Continuing Medical Education (CME)
CME Programs on Encainide
International
Encainide en Espanol Encainide en Francais
Business
Encainide in the Marketplace Patents on Encainide
Experimental / Informatics
List of terms related to Encainide

Encainide
Clinical data
Trade names	Enkaid
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a605040
ATC code	C01BC08 (WHO) ;
Legal status
Legal status	Withdrawn;
Identifiers
	IUPAC name 4-methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide;
CAS Number	66778-36-7;
PubChem CID	48041;
DrugBank	DB01228 ;
ChemSpider	43697 ;
UNII	SY3J0147NB;
KEGG	D07894 ;
ChEBI	CHEBI:4788 ;
ChEMBL	ChEMBL315838;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C22H28N2O2
Molar mass	352.47 g/mol
3D model (JSmol)	Interactive image;
	SMILES CC(CN1CCCCC1)c3ccccc3NC(=O)c2ccc(OC)cc2;
	InChI InChI=1S/C22H28N2O2/c1-24-16-6-5-8-19(24)13-10-17-7-3-4-9-21(17)23-22(25)18-11-14-20(26-2)15-12-18/h3-4,7,9,11-12,14-15,19H,5-6,8,10,13,16H2,1-2H3,(H,23,25) ; Key:PJWPNDMDCLXCOM-UHFFFAOYSA-N ;
(verify)

VisualWikitext

Latest revision as of 22:14, 23 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Encainide (trade name Enkaid) is a class Ic antiarrhythmic agent. It is no longer used because of its frequent proarrhythmic side effects.^[1]

References

↑ PMID 1900101 (PMID 1900101)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Template:Antiarrhythmic agents

[1] PMID 1900101 (PMID 1900101)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

[1]

@@ Line 2: / Line 2: @@
 | verifiedrevid = 443722856
 | IUPAC_name = 4-methoxy-''N''-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide
-| image = EncainideRedrawn.svg
+| image = Encainide.png
 <!--Clinical data-->
@@ Line 53: / Line 53: @@
 | StdInChIKey = PJWPNDMDCLXCOM-UHFFFAOYSA-N
 }}
+__NOTOC__
+{{SI}}
+{{CMG}}
+==Overview==
 '''Encainide''' (trade name '''Enkaid''') is a class Ic [[antiarrhythmic agent]]. It is no longer used because of its frequent [[proarrhythmic]] side effects.<ref>{{cite pmid|1900101}}</ref>
-==See also==
-* [[Cardiac Arrhythmia Suppression Trial]]
 ==References==
-{{reflist}}
+{{reflist|2}}
-{{Sodium channel blockers}}
 {{Antiarrhythmic agents}}
 [[Category:Antiarrhythmic agents]]
-[[Category:Piperidines]]
+[[Category:Cardiovascular Drugs]]
-[[Category:Sodium channel blockers]]
+[[Category:Drug]]
-[[Category:Benzanilides]]
-[[Category:Phenol ethers]]

Encainide: Difference between revisions

Latest revision as of 22:14, 23 July 2014

Overview

References

Navigation menu